Value Star Asset Management Hong Kong Ltd Has $4.26 Million Position in HCA Healthcare, Inc. $HCA

Value Star Asset Management Hong Kong Ltd cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 16.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,000 shares of the company’s stock after selling 2,000 shares during the quarter. HCA Healthcare makes up about 8.7% of Value Star Asset Management Hong Kong Ltd’s holdings, making the stock its 5th biggest holding. Value Star Asset Management Hong Kong Ltd’s holdings in HCA Healthcare were worth $4,262,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter worth about $1,021,000. NewEdge Advisors LLC raised its stake in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Stephens Inc. AR lifted its stake in shares of HCA Healthcare by 3.2% during the 2nd quarter. Stephens Inc. AR now owns 8,500 shares of the company’s stock valued at $3,256,000 after buying an additional 265 shares in the last quarter. Finally, Avidian Wealth Enterprises LLC increased its stake in HCA Healthcare by 12.4% in the 2nd quarter. Avidian Wealth Enterprises LLC now owns 786 shares of the company’s stock worth $301,000 after buying an additional 87 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 15,214 shares of company stock valued at $7,797,595. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA traded up $2.78 during mid-day trading on Friday, reaching $531.44. 40,518 shares of the company’s stock traded hands, compared to its average volume of 1,097,514. The stock’s 50-day moving average is $487.04 and its two-hundred day moving average is $453.28. The stock has a market cap of $118.84 billion, a P/E ratio of 18.68, a P/E/G ratio of 1.64 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $552.90.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the company earned $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on HCA shares. Stephens boosted their price target on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Cantor Fitzgerald raised their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Truist Financial boosted their target price on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. JPMorgan Chase & Co. boosted their price target on shares of HCA Healthcare from $420.00 to $535.00 in a research report on Friday. Finally, Argus boosted their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $530.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.